RESEARCHER PROFILE (Filmed November 2023)
Dr Brendan Shannon
Head of Postgraduate Programs
Monash University
Melbourne, Australia
Dr Brendan Shannon is a registered paramedic and Head of Postgraduate Programs and Deputy Head of Department of Paramedicine at Monash University.
Transitioning from 12 years clinical work as a paramedic to academia, Dr. Brendan Shannon understands the importance of research and education in the field of healthcare. He became a paramedic, pursued higher education, and transitioned into academia while still maintaining a clinical workload.
Brendan has balanced clinical and academic experience throughout his career and his research is closely informed by paramedicine practice.
Brendan has a keen research interest in alternative care pathways, non-transport, referral services, paramedic practitioners and community paramedicine. His Doctoral research focused on investigating the experiences of health services when implementing alternative care pathways.
These pathways are designed to deliver care in community settings for populations that are traditionally underserved. The programs examined were found to effectively address complex patients’ needs in community settings.
Dr. Shannon is driven to help people’s lives be better, particularly those who don’t have the privileges as others. His focus is on treating underserved communities with chronic diseases and complex social conditions, who frequently use healthcare services, through community paramedicine programs, as well as patients who frequently utilise healthcare services like the emergency department.
“The intersection of chronic disease and complex social conditions presents a unique challenge in healthcare. Researching programs to increase access to care for underserved patients within the community is a big umbrella term with lots of avenues to explore”, says Dr Shannon.
Apart from research, having a purpose to help others and teaching, Dr Shannon has a passion for restoring old cars nurtured from family influences. He also takes part in amateur martial arts, in particular Brazilian jiu-jitsu.
You Might also like
-
Supportive care for people living with or beyond cancer treatment
Dr Hannah Wardill is a Hospital Research Foundation Fellow and lead of the Supportive Oncology Research Group (SORG), in the School of Biomedicine, University of Adelaide and Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI). She is an Executive Board Member of the Multinational Association for Supportive Care in Cancer / International Society for Oral Oncology (MASCC/ISOO) and Chair of both MASCC/ISOO Patient Partnership Committee & the Palliative Care Clinical Studies Collaborative (PaCCSC) Cancer Symptom Trials (Gut Dysfunction Node; supported by Cancer Australia).
-
Mechanisms of resistance to menin inhibitor therapy and Acute Myeloid Leukaemia
Dr Rithin Nedumannil (MBBS, MPH, FRACP, FRCPA) is a PhD candidate at the University of Melbourne, undertaking his doctoral studies in collaboration with the Cambridge Stem Cell Institute (Cambridge, UK) and the Peter MacCallum Cancer Centre (Melbourne, Australia). He is a clinical haematologist and haematopathologist with current appointments at Peter MacCallum Cancer Centre, the Royal Melbourne Hospital, Austin Health and Northern Health.
-
Infections and other lung diseases using models of human lung tissue grown from stem cells
Dr Rhiannon Werder is a Team Leader at Murdoch Children’s Research Institute leading a multidisciplinary team, combining expertise in stem cell biology and immunology, to develop new therapies for lung diseases. Her research centres around induced pluripotent stem cells to investigate respiratory diseases, spanning acute respiratory infections to chronic lung diseases. Using stem cells, Dr Werder’s team creates models of human lung tissue. With these models, Dr Werder is investigating how human-specific pathogens infect different regions of the lung, the ensuing immune responses, and how the lung repairs itself after infections, especially in people with preexisting lung diseases.